Core Viewpoint - The company Zhongsheng Pharmaceutical (002317.SZ) has announced that its drug Angladiwei tablets (brand name: Anruiwei®) is effective for treating adult patients with uncomplicated influenza A, showing strong inhibitory activity against various influenza virus strains, including those resistant to Oseltamivir and Baloxavir [1] Company Summary - The Angladiwei tablets are specifically indicated for adult patients with uncomplicated influenza A [1] - Preclinical research indicates the drug's effectiveness against multiple influenza virus strains, including highly pathogenic avian influenza and resistant strains [1]